Literature DB >> 20511060

The role of vitamin D in cancer prevention and treatment.

Aruna V Krishnan1, Donald L Trump, Candace S Johnson, David Feldman.   

Abstract

Calcitriol (1,25-dihydroxyvitamin D(3)), the hormonally active form of vitamin D, exerts growth inhibitory and prodifferentiating effects on many malignant cells and retards tumor growth in animal models. Calcitriol is being evaluated as an anticancer agent in several human cancers. The mechanisms underlying the anticancer effects of calcitriol include inhibition of cell proliferation, stimulation of apoptosis, suppression of inflammation, and inhibition of tumor angiogenesis, invasion, and metastasis. This review discusses some of the molecular pathways mediating these anticancer actions of calcitriol and the preclinical data in cell culture and animal models. The clinical trials evaluating the use of calcitriol and its analogues in the treatment of patients with cancer are described. The reasons for the lack of impressive beneficial effects in clinical trials compared with the substantial efficacy seen in preclinical models are discussed. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20511060      PMCID: PMC5788175          DOI: 10.1016/j.ecl.2010.02.011

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN: 0889-8529            Impact factor:   4.741


  140 in total

Review 1.  HIF-1 as a target for drug development.

Authors:  Amato Giaccia; Bronwyn G Siim; Randall S Johnson
Journal:  Nat Rev Drug Discov       Date:  2003-10       Impact factor: 84.694

2.  Phase I/II study of 19-nor-1alpha-25-dihydroxyvitamin D2 (paricalcitol) in advanced, androgen-insensitive prostate cancer.

Authors:  Gary G Schwartz; M Craig Hall; Diana Stindt; Suzanne Patton; James Lovato; Frank M Torti
Journal:  Clin Cancer Res       Date:  2005-12-15       Impact factor: 12.531

3.  Calcitriol (1,25-dihydroxycholecalciferol) enhances paclitaxel antitumor activity in vitro and in vivo and accelerates paclitaxel-induced apoptosis.

Authors:  P A Hershberger; W D Yu; R A Modzelewski; R M Rueger; C S Johnson; D L Trump
Journal:  Clin Cancer Res       Date:  2001-04       Impact factor: 12.531

4.  Inhibitory effects of 1alpha,25-dihydroxyvitamin D(3) on the G(1)-S phase-controlling machinery.

Authors:  S S Jensen; M W Madsen; J Lukas; L Binderup; J Bartek
Journal:  Mol Endocrinol       Date:  2001-08

5.  Carcinogenesis in inflammatory bowel disease.

Authors:  Laszlo Herszenyi; Pal Miheller; Zsolt Tulassay
Journal:  Dig Dis       Date:  2007       Impact factor: 2.404

6.  Do sunlight and vitamin D reduce the likelihood of colon cancer?

Authors:  C F Garland; F C Garland
Journal:  Int J Epidemiol       Date:  1980-09       Impact factor: 7.196

7.  Metabolic effects of synthetic calcitriol (Rocaltrol) in the treatment of postmenopausal osteoporosis.

Authors:  J C Gallagher
Journal:  Metabolism       Date:  1990-04       Impact factor: 8.694

8.  The combination of a potent vitamin D3 analog, EB 1089, with ionizing radiation reduces tumor growth and induces apoptosis of MCF-7 breast tumor xenografts in nude mice.

Authors:  Sujatha Sundaram; Andrea Sea; Stephanie Feldman; Rendall Strawbridge; P Jack Hoopes; Eugene Demidenko; Lise Binderup; David A Gewirtz
Journal:  Clin Cancer Res       Date:  2003-06       Impact factor: 12.531

Review 9.  Vascular endothelial growth factor and its relationship to inflammatory mediators.

Authors:  Laura S Angelo; Razelle Kurzrock
Journal:  Clin Cancer Res       Date:  2007-05-15       Impact factor: 12.531

10.  A phase II study of the vitamin D analogue Seocalcitol in patients with inoperable hepatocellular carcinoma.

Authors:  K Dalhoff; J Dancey; L Astrup; T Skovsgaard; K J Hamberg; F J Lofts; O Rosmorduc; S Erlinger; J Bach Hansen; W P Steward; T Skov; F Burcharth; T R J Evans
Journal:  Br J Cancer       Date:  2003-07-21       Impact factor: 7.640

View more
  67 in total

Review 1.  Vitamin D: Implications for ocular disease and therapeutic potential.

Authors:  Rose Y Reins; Alison M McDermott
Journal:  Exp Eye Res       Date:  2015-02-25       Impact factor: 3.467

2.  Inhibition of Mouse Breast Tumor-Initiating Cells by Calcitriol and Dietary Vitamin D.

Authors:  Youngtae Jeong; Srilatha Swami; Aruna V Krishnan; Jasmaine D Williams; Shanique Martin; Ronald L Horst; Megan A Albertelli; Brian J Feldman; David Feldman; Maximilian Diehn
Journal:  Mol Cancer Ther       Date:  2015-05-01       Impact factor: 6.261

3.  BRAF signals to pro-apoptotic BIM to enhance AraC cytotoxicity induced in AML cells by Vitamin D-based differentiation agents.

Authors:  Xuening Wang; Jonathan S Harrison; George P Studzinski
Journal:  J Steroid Biochem Mol Biol       Date:  2016-09-13       Impact factor: 4.292

4.  Vitamin D and tyrosine kinase inhibitors in chronic myeloid leukemia.

Authors:  Leonardo Campiotti; Elena Bolzacchini; Matteo Basilio Sutter; Andrea Maria Maresca; Anna Maria Grandi; Luigina Guasti
Journal:  Intern Emerg Med       Date:  2018-09-25       Impact factor: 3.397

Review 5.  The potential therapeutic benefits of vitamin D in the treatment of estrogen receptor positive breast cancer.

Authors:  Aruna V Krishnan; Srilatha Swami; David Feldman
Journal:  Steroids       Date:  2012-07-16       Impact factor: 2.668

Review 6.  Vitamin D and cancer: the promise not yet fulfilled.

Authors:  Daniel D Bikle
Journal:  Endocrine       Date:  2014-01-09       Impact factor: 3.633

7.  Is vitamin D deficiency a cause of increased morbidity and mortality at older age or simply an indicator of poor health?

Authors:  Ben Schöttker; Kai-Uwe Saum; Laura Perna; José Manuèl Ordóñez-Mena; Bernd Holleczek; Hermann Brenner
Journal:  Eur J Epidemiol       Date:  2014-03-29       Impact factor: 8.082

8.  Prevalence of Vitamin D Deficiency in Children (6-18 years) Residing in Kullu and Kangra Districts of Himachal Pradesh, India.

Authors:  Umesh Kapil; Ravindra Mohan Pandey; Brij Sharma; Lakshmy Ramakrishnan; Neetu Sharma; Gajendra Singh; Neha Sareen
Journal:  Indian J Pediatr       Date:  2018-01-02       Impact factor: 1.967

9.  Vitamin D regulates prostate cell metabolism via genomic and non-genomic mitochondrial redox-dependent mechanisms.

Authors:  Chuck C Blajszczak; Larisa Nonn
Journal:  J Steroid Biochem Mol Biol       Date:  2019-09-28       Impact factor: 4.292

10.  Combination of oral vitamin D3 with photodynamic therapy enhances tumor cell death in a murine model of cutaneous squamous cell carcinoma.

Authors:  Sanjay Anand; Kishore R Rollakanti; Ronald L Horst; Tayyaba Hasan; Edward V Maytin
Journal:  Photochem Photobiol       Date:  2014-05-26       Impact factor: 3.421

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.